ISLAMABAD — Authorities in Islamabad raided Excel Labs over suspected counterfeit Flu vaccines, and arrested CEO and two others while seizing 27 injections.
The operation comes amid citizen’s complaint alleging that Influvac Tetra vaccines were being administered at the laboratory. According to a spokesperson for the Ministry of National Health Services, the Drug Control ICT team launched the inspection under the supervision of Chief Drug Inspector Sardar Shabbir.
The authorities reportedly discovered vaccine stock whose authenticity had come under scrutiny amid a nationwide shortage of genuine flu vaccines.
The enforcement operation resulted in the reported detention of three individuals associated with Excel Diagnostic Lab, a private diagnostic chain headquartered at Reshi Building, 110 Fazal-ul-Haq Road, Blue Area, Islamabad, with branches elsewhere in the country. Those identified in the report were CEO Dr. Naseer Ahmed, manager Bilal Abbasi and laboratory employee Sher Dil.
Investigators reportedly confiscated 27 Influvac Tetra vaccine injections along with laboratory records relevant to the suspected vaccine stock. Officials alleged that the laboratory administration resisted the inspection, prompting the enforcement team to seek assistance from the Federal Investigation Agency (FIA). With additional support, the authorities completed the operation and secured the material for further investigation.
The ministry spokesperson reportedly said that the vaccine had not been imported into Pakistan during the current year. The same account identified Lot Number 913, claiming that it had previously been declared counterfeit by a Drug Testing Laboratory. However, the publicly available DRAP rapid alert reviewed for Influvac Tetra identifies Batch P13, not 913. Whether the two numbers refer to different batches or reflect a reporting discrepancy remains unclear.
Fake Flu Vaccines Alert
This raid comes amid influenza vaccine shortages and counterfeit products entering Pakistan’s medicine supply chain. Drug Regulatory Authority of Pakistan issued an alert confirming that Influvac Tetra Batch P13 was falsified and outside the legitimate supply network.
Last month, DRAP had flagged another influenza vaccine, Vaxigrip Tetra Batch Y4B34, after information emerged that the identified batch had never been officially imported or distributed in Pakistan. The warnings have heightened concerns about the risks faced by patients seeking seasonal influenza protection.
Regulators caution that counterfeit vaccines may fail to provide the intended immune protection and could expose recipients to unknown health risks.
Federal Health Minister Mustafa Kamal reportedly welcomed the Islamabad enforcement operation and directed authorities to pursue strict legal action against individuals found responsible. The minister stressed that public health could not be compromised and reaffirmed the federal government’s commitment to eliminating counterfeit medicines from the healthcare system.
The ministry’s response signals a broader effort to strengthen oversight of pharmaceutical products, medical institutions and vaccine distribution networks.
The case now raises questions about how the disputed influenza vaccines entered the laboratory’s supply chain, where they originated and whether any doses from the suspected stock were administered to patients. Investigators are reportedly examining the confiscated records and seeking to identify other individuals potentially connected to the distribution of the vaccines.
FIA seeks nod to arrest Mustafa Kamal as Hajj, Umrah vaccine probe deepens


















